Annual Shareholders Equity
$292.26 M
+$256.10 M+708.36%
31 December 2023
Summary:
CymaBay Therapeutics annual stockholders equity is currently $292.26 million, with the most recent change of +$256.10 million (+708.36%) on 31 December 2023. During the last 3 years, it has risen by +$159.32 million (+119.85%).CBAY Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$292.26 M
-$33.94 M-10.40%
31 December 2023
Summary:
CymaBay Therapeutics quarterly stockholders equity is currently $292.26 million, with the most recent change of -$33.94 million (-10.40%) on 31 December 2023.CBAY Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBAY Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +119.8% | +119.8% |
| 5 y5 years | +56.8% | +56.8% |
CBAY Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | -10.4% |
CymaBay Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $292.26 M(+708.4%) | $292.26 M(-10.4%) |
| Sept 2023 | - | $326.19 M(+200.9%) |
| June 2023 | - | $108.41 M(+4.0%) |
| Mar 2023 | - | $104.19 M(+188.2%) |
| Dec 2022 | $36.15 M(-72.8%) | $36.15 M(-39.9%) |
| Sept 2022 | - | $60.18 M(-27.0%) |
| June 2022 | - | $82.46 M(-23.2%) |
| Mar 2022 | - | $107.38 M(-19.2%) |
| Dec 2021 | $132.94 M(-6.8%) | $132.94 M(+52.7%) |
| Sept 2021 | - | $87.06 M(-18.7%) |
| June 2021 | - | $107.09 M(-16.1%) |
| Mar 2021 | - | $127.65 M(-10.6%) |
| Dec 2020 | $142.71 M(-23.4%) | $142.71 M(-8.9%) |
| Sept 2020 | - | $156.63 M(-5.4%) |
| June 2020 | - | $165.61 M(-5.4%) |
| Mar 2020 | - | $175.05 M(-6.1%) |
| Dec 2019 | $186.35 M(+9.3%) | $186.35 M(-12.3%) |
| Sept 2019 | - | $212.59 M(-9.9%) |
| June 2019 | - | $236.06 M(-8.4%) |
| Mar 2019 | - | $257.63 M(+51.2%) |
| Dec 2018 | $170.42 M | $170.42 M(-9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $188.13 M(-5.6%) |
| June 2018 | - | $199.21 M(-6.1%) |
| Mar 2018 | - | $212.20 M(+149.8%) |
| Dec 2017 | $84.95 M(+2057.7%) | $84.95 M(-1.8%) |
| Sept 2017 | - | $86.50 M(+3944.1%) |
| June 2017 | - | $2.14 M(-76.8%) |
| Mar 2017 | - | $9.23 M(+134.4%) |
| Dec 2016 | $3.94 M(-86.0%) | $3.94 M(-61.4%) |
| Sept 2016 | - | $10.21 M(-33.8%) |
| June 2016 | - | $15.42 M(-29.4%) |
| Mar 2016 | - | $21.85 M(-22.3%) |
| Dec 2015 | $28.11 M(+103.0%) | $28.11 M(-16.1%) |
| Sept 2015 | - | $33.49 M(+89.4%) |
| June 2015 | - | $17.68 M(-3.2%) |
| Mar 2015 | - | $18.27 M(+31.9%) |
| Dec 2014 | $13.85 M(-25.5%) | $13.85 M(-47.0%) |
| Sept 2014 | - | $26.13 M(+208.3%) |
| June 2014 | - | $8.48 M(-25.5%) |
| Mar 2014 | - | $11.38 M(-38.8%) |
| Dec 2013 | $18.60 M(-105.7%) | $18.60 M |
| Dec 2012 | -$328.57 M | - |
FAQ
- What is CymaBay Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for CymaBay Therapeutics?
- What is CymaBay Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for CymaBay Therapeutics?
What is CymaBay Therapeutics annual stockholders equity?
The current annual shareholders equity of CBAY is $292.26 M
What is the all time high annual shareholders equity for CymaBay Therapeutics?
CymaBay Therapeutics all-time high annual stockholders equity is $292.26 M
What is CymaBay Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CBAY is $292.26 M
What is the all time high quarterly shareholders equity for CymaBay Therapeutics?
CymaBay Therapeutics all-time high quarterly stockholders equity is $326.19 M